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Abstract
Background: Ischemia/reperfusion (I/R) injury is associated with systemic inflammatory response. Macrophage migration
inhibitory factor (MIF) has been implicated in many inflammatory processes. Tanshinone IIA (TSA) is one of the active
ingredients in danshen, which derived from the dried root or rhizome of Salviae miltiorrhizae Bge. Recent studies have
demonstrated that TSA has protective effects against focal cerebral I/R injury. However, little is known about the underlying
mechanisms. Here we put forward the hypothesis that TSA acts through inhibition of MIF expression during focal cerebral I/
R injury in rats.
Methodology/Principal Findings: Rats were subjected to middle cerebral artery occlusion (MCAO) for 2 hours. This was
followed by reperfusion. We measured neurological deficits, brain water content, and infarct volume, and found that
neurological dysfunction, brain edema, and brain infarction were significantly attenuated by TSA 6 hours after reperfusion.
We also measured myeloperoxidase (MPO) activity at 6 and 24 hours, and found that neutrophil infiltration was significantly
higher in the vehicle+I/R group than in the TSA+I/R group. ELISA demonstrated that TSA could inhibit MIF expression and
the release of TNF-a and IL-6 induced by I/R injury. Western blot analysis and immunofluorescence staining showed that MIF
expression was significantly lower in the TSA+I/R group than in the vehicle+I/R group. MIF was found almost all located in
neurons and hardly any located in astrocytes in the cerebral cortex. Western blot analysis and EMSA demonstrated that NF-
kB expression and activity were significantly increased in the vehicle+I/R group. However, these changes were attenuated
by TSA.
Conclusion/Significance: Our results suggest that TSA helps alleviate the proinflammatory responses associated with I/R-
induced injury and that this neuroprotective effect may occur through down-regulation of MIF expression in neurons.
Citation: Chen Y, Wu X, Yu S, Lin X, Wu J, et al. (2012) Neuroprotection of Tanshinone IIA against Cerebral Ischemia/Reperfusion Injury through Inhibition of
Macrophage Migration Inhibitory Factor in Rats. PLoS ONE 7(6): e40165. doi:10.1371/journal.pone.0040165
Editor: Wing-ho Yung, The Chinese University of Hong Kong, Hong Kong
Received February 22, 2012; Accepted June 2, 2012; Published June 29, 2012
Copyright:  2012 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from National Nature Science Foundation of China (No. 30900457 and No. 81070917). The funders had no role in
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: blys01@163.com (YZ); yangyang741022@sina.com (JZ)
Introduction
Stroke is the second most common cause of death and a major
cause of disability worldwide [1,2]. The inflammatory response to
brain injury plays a vital role in the pathogenesis of stroke [3,4].
The selective inhibition of inflammatory cytokine activity remains
an important goal in the effective treatment of brain ischemia and
reperfusion (I/R) injury. Recent studies have demonstrated that
agents with anti-inflammatory action have therapeutic potential in
experimental models of stroke [5,6].
Macrophage migration inhibitory factor (MIF) is a proinflam-
matory cytokine derived from many cell types [7]. After activating
nuclear factor kB (NF-kB), MIF induces the production of
subsequent cytokines [8]. There is ample evidence indicating that
MIF expression is increased at the transcriptional level in human
stroke patients and in animal models of focal ischemia [9]. This
suggests that inhibition of MIF may serve as a viable strategy for
the treatment of ischemic stroke.
Danshen, a very important component of Chinese medicine
derived from the dried root or rhizome of Salviae miltiorrhizae Bge
(SM), has been widely used in China for the treatment of
cerebrovascular conditions, such as ischemic stroke [10,11].
Tanshinone IIA (TSA), whose IUPAC name is Phenanthro [1,
2-b] furan-10, 11-dione, 6, 7, 8, 9-tetrahydro-1, 6, 6-trimethyl
being a derivative of phenanthrenequinone, is a key active
component of danshen (Fig. 1) [12]. Recent studies have
demonstrated that TSA has protective effects against focal cerebral
I/R injury [13,14]. Our previous study indicated that 25 mg/kg
TSA administered 10 minutes after middle cerebral artery
occlusion (MCAO) showed most protective effects [15]. However,
little is known about the mechanism responsible for the effects of
TSA. Researchers have reported that TSA attenuates seawater-
aspiration-induced lung injury by inhibiting MIF [16]. Given the
importance of MIF, this study puts forward the hypothesis that the
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e40165neuroprotective effects of TSA may be associate inhibition of the
MIF pathway.
Results
Effects of TSA on Neurological Deficit, Brain Water
Content, and Infarction
To determine the neuroprotective effect of TSA against I/R
injury, we measured the neurological score, brain water content,
and infarct volume with and without administration of TSA. As
shown in Figures 2A, C, and D, relative to the vehicle+I/R group,
neurological scores and cerebral infarct volumes were significantly
decreased after treatment with TSA (P,0.05). As shown in
Figure 2B, in the sham group, the brain water content was
78.2860.16%. In the TSA+I/R group, the brain water content
was lower, 79.5260.21%, than in the vehicle+I/R group
81.6460.55% (P,0.05). No significant differences were observed
in contralateral hemispheres (P.0.05).
Effects of TSA on Neutrophil Infiltration in the Brain
Tissues
Next, we performed a myeloperoxidase (MPO) activity assay to
determine the neutrophil influx in the ischemia cerebral cortex
(Figure 3). MPO activity was significantly higher in the vehicle+I/
R group than the sham group at different points in time (P,0.05).
The increased MPO activity was reduced by treatment with TSA
after I/R injury (P,0.05).
Effects of TSA on MIF and Cytokine Expression Induced
by Reperfusion at Different Times
We also examined the effect of TSA on the expression of MIF,
tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6) induced
by the reperfusion at different points in time. As shown in
Figure 4A, MIF content was significantly higher in the vehicle+I/
R group than in the sham group at 1 hour, 3 hours, and 6 hours
after reperfusion, showing a maximum difference at 24 hours
(P,0.05). TSA markedly inhibited the expression of MIF at
different points in time after reperfusion (P,0.05). No difference in
TNF-a expression was observed at 1 hour. The elevation of TNF-
a levels was observed 3 hours and 6 hours after reperfusion and
found to reach a maximum at 24 hours after reperfusion (P,0.05,
Figure 4B). The change in IL-6 expression was similar to TNF-a
level (Figure 4C). The increased expression of TNF-a and IL-6 at
3 hours, 6 hours, and 24 hours after reperfusion were also down-
regulated by TSA treatment (P,0.05).
Effects of TSA on Expression of MIF and NF-kB p65
Western blot analysis (Figure 5) of brain samples showed that
the expression level of MIF was increased in the vehicle+I/R
group 24 hours after focal cerebral I/R and significantly lower in
the TSA treatment group than in the vehicle+I/R group (P,0.05).
The expression level of NF-kB p65 was also increased in the
vehicle+I/R group 24 hours after focal cerebral I/R and
significantly lower in the TSA treatment group than in the
vehicle+I/R group (P,0.05).
Effects of TSA on NF-kB Activation
NF-kB activation 24 hours after reperfusion was assessed by
electrophoretic mobility shift assay (EMSA). As shown in Figure 6,
low NF-kB binding activity was observed in sham-operated rats.
I/R induced activation of NF-kB in the ipsilateral hemispheres.
NF-kB binding activity was increased in the vehicle+I/R group 24
hours after focal cerebral I/R and significantly lower in the TSA
treatment group than in the vehicle+I/R group (P,0.05).
Effects of TSA on Location of MIF
As shown in Figure 7 and Figure 8, in the cerebral cortex, MIF
was found almost all located in neurons and hardly any located in
astrocytes. Following surgery, MIF showed significant increases
around the infarct core in the vehicle+I/R group and significantly
decreases in the TSA+I/R group 24 hours after reperfusion.
Discussion
MCAO is a classical model of cerebral ischemia [17,18]. In this
study, we have shown that TSA can reduce MPO activity after
focal cerebral I/R injury. We also demonstrated that TSA can
inhibit MIF expression, NF-kB activity and the release of TNF-a
and IL-6 induced by I/R injury. TSA was here found to provide
neuronal protection partly through its anti-inflammatory effect
associated with down-regulation of MIF. Our results also indicated
that MIF is presenting almost all located in neurons and rare
located in astrocytes.
Danshen, a very important traditional Chinese medicinal herb,
has been commonly used in traditional Chinese medicine practice
for over a thousand years in the treatment of coronary artery
disease and cerebrovascular diseases including stroke. The
therapeutic efficacy of Danshen in stroke has been confirmed by
clinical studies suggesting that Danshen preparations were
neuroprotective with few or no adverse effects [19]. In recent
decades, TSA being one of the active ingredients in danshen has
been widely used in research for the treatment of cadiovascular
and cerebrovascular disease and no adverse effects have been
reported till now. Lam et al. reported that, TSA was detected in
blood within 5 minutes after intraperitoneal injection and also
detected in the brain 5 minutes after injection, showing that the
drug was able to penetrate the blood brain barrier. The level in the
brain reached the peak at 60 minutes and decreased slowly over
several hours, and was undetectable after 8 hours, showing the
drug was able to affect the brain [10]. In our previous study, we
found that 25 mg/kg TSA was an optimal concentration. A dose
of 25 mg/kg TSA or 1 ml/kg PBS including 1% dimethyl
sulfoxide (DMSO) was given at 3 d before MCAO (once a day
for 2 consecutive days with the last injection 2 h before MCAO),
10 min after MCAO, 0 h after reperfusion, and 2 h after
reperfusion. The results showed that 25 mg/kg TSA reduced
infarct size relative to the vehicle+I/R group at all points in time,
of which 10 min after MCAO was the most significant [15]. So we
chose to administer 25 mg/kg TSA 10 min after MCAO in the
present experiments.
Figure 1. Chemical structure of Tanshinone IIA.
doi:10.1371/journal.pone.0040165.g001
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severely compromised and may not be repairable. The surround-
ing tissue, the peri-infarct region, may be subjected to further
damage through activation of secondary inflammatory and
neurodegenerative cascades [20]. Kim et al. and Phillips et al.
reported that inflammatory and immunological reactions are
involved in the pathogenesis of cerebral ischemia following blood
reperfusion to the surrounding tissue [21,22]. In this way, the
inhibition of inflammatory responses, especially inhibition of
inflammatory cytokine activities at the early stage of ischemia,
may constitute an attractive therapeutic strategy. Our results
demonstrated that I/R can lead to neurological dysfunction, brain
edema, brain infarction, and neutrophil infiltration. However,
these changes were attenuated by TSA. This indicates that the
protective effect of TSA may be associated with inhibition of
inflammation.
MIF is an upstream regulator of inflammatory immune
processes [23]. After activating NF-kB, MIF can induce the
production of subsequent cytokines [8]. A recent study has
demonstrated that MIF KO mice with I/R had reduced
expression of various inflammatory cytokines and mediators
[24]. Wang et al. showed that MIF expression is increased at
the transcriptional level in human stroke patients and in animal
models of focal ischemia [9]. This suggests that inhibition of MIF
may represent a suitable treatment strategy for ischemic stroke.
Our results demonstrated that TSA could inhibit MIF expression,
NF-kB activity and the release of TNF-a and IL-6 in the ischemic
cortex induced by cerebral I/R injury at different points in time.
This provided the evidence that MIF associated with the NF-kB
activation pathway plays an important role in the injury processes
after stroke. Inhibition of the up-regulation of MIF, NF-kB, TNF-
a and IL-6 during the early stage brings great benefits to the
organism.
Ina ´cio et al. showed that, 5 days after surgery, MIF increases
around the infarct core in the permanent middle cerebral artery
occlusion in rats, where it is located to neurons and astrocytes [25].
Our results showed that, in the cerebral cortex, MIF is present
almost all located in neurons and hardly any located in astrocytes.
Following MCAO, MIF significantly increased around the infarct
core in the vehicle+I/R group and significantly decreased in the
TSA+I/R group at 24 hours after reperfusion.
As a regulator of death and survival proteins, NF-kB plays an
important role in neuron survival within the central nervous
system. Persistent activation of NF-kB renders neurons vulnerable
Figure 2. Effects of TSA on neurological deficit, brain water content, and infarction. As shown in Fig. 2, the (A) neurological score and (C
and D) infarct volume were significantly higher in the vehicle+I/R group than in the sham group after reperfusion at 6 hours (#P,0.05) and lower in
the TSA+I/R group than in the vehicle+I/R group (*P,0.05, one-way ANOVA, n=5–6 for each group). (B) The brain water content of the ipsilateral
hemispheres was similar to the neurological score and infarct volume. No difference was found in contralateral hemispheres (P.0.05).
doi:10.1371/journal.pone.0040165.g002
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binding activity is increased in the vehicle+I/R group 24 hours
after focal cerebral I/R and significantly lower in the TSA
treatment group than in the vehicle+I/R group. Based on these
results, treatment with TSA can be said to hamper the movement
of NF-kB from the cytoplasm to the nucleus. Moreover, Jang et al.
reported that TSA inhibited NF-kB-DNA complex, NF-kB
binding activity, and the phosphorylation of IkBa in RAW
264.7 cells stimulated with LPS [28]. Their reports are consistent
with our study and also suggest that TSA may inhibit IkBa
degradation and NF-kB activation via suppression of the NIK–
IKK pathway as well as the MAPKs (p38, ERK1/2, and JNK)
pathway. Whether TSA inhibits NF-kB activation in the brain also
via these pathways, it is still unclear and worth of further
exploration.
Collectively, our results suggest that TSA has a protective effect
on the brain I/R injury and that this effect takes place partly
through its anti-inflammatory effect, which is associated with
down-regulation of MIF in neurons.
Materials and Methods
Chemicals
TSA (purity 99%, HPLC) was obtained from Sciphar Biotech-
nology Co (Shaanxi, China). TSA was dissolved in phosphate-
buffered saline (PBS) including 1% DMSO before the experi-
ments. 2,3,5-triphenyltetrazolium chloride (TTC) was purchased
from Sigma-Aldrich Co. (St. Louis, MO, U.S.). A determination of
MPO kit was purchased from the Jiancheng Bioengineering
Institute (Nanjing, China). Enzyme-linked immunosorbent assay
(ELISA) kits were purchased from R&D Systems (Minneapolis,
MN, U.S). MIF, NF-kB p65, and b-actin antibodies were
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, U.S.). NeuN antibody was obtained from Merck Millipore
(MA, U.S.). GFAP antibody was obtained from Boster Bio-
engineering Co. Ltd. (Wuhan, China).
Animals
Adult male Sprague-Dawley rats weighing 250620 g (n=132),
age 9064 d, were bred and held in the Experimental Animal
Center of Chongqing Medical University. The protocol was
approved by the institutional animal care and use committee and
the local experimental ethics committee. All rats were allowed free
access to food and water before the operation under optimal
conditions (12/12 hours light/dark with humidity 6065%,
2263uC).
Rat Model of Transient Focal Cerebral Ischemia
Transient cerebral ischemia was induced by MCAO in rats as
described in detail in our previously study [29,30]. The middle
cerebral artery was occluded by insertion of a nylon filament
(diameter 0.24–0.28 mm). After 2 hours of ischemia, the nylon
filament was carefully pulled out to establish reperfusion. Rats that
did not show neurological deficits immediately after reperfusion
(neurological score ,1) were excluded from the study. Rats that
showed neurological deficits immediately after reperfusion (neu-
rological score .0) but were found to be experiencing skull base or
subarachnoid hemorrhage were also excluded from the study. The
total elimination rate was 14/132. Sham-operated animals
underwent the same surgical procedures without occlusion of the
common carotid arteries.
Groups and Drug Administration
One hundred and thirty-two rats were divided into 3 groups
randomly: sham group, vehicle+I/R group, 25 mg/kg TSA+I/R
group (n=44 for each group). TSA was injected intraperitoneally
10 minutes after MCAO. Our previously study demonstrated that
25 mg/kg TSA 10 minutes after MCAO had significant protective
effects [15]. A vehicle of 1 ml/kg PBS including 1% DMSO was
given.
Assessment of Neurological Deficits
Neurological testing of the vehicle- and drug-treated groups was
carried out after 2 hours of MCAO by one examiner blinded to
the experimental groups according to the method described by
Longa et al. [18]. Neurological findings were scored on a five-
point scale: 0, no neurological deficits; 1, failure to extend right
forepaw fully; 2, circling to the right; 3, falling to the right; and 4,
inability to walk spontaneously combined with depressed levels of
consciousness.
Figure 3. Effects of TSA on MPO activity. MPO activity at (A) 6
hours and (B) 24 hours reflects neutrophil infiltration in the ischemia
cerebral cortex. MPO activities were significantly increased in the
vehicle+I/R group at the two time points and lower in the TSA+I/R
group than in the vehicle+I/R group. Data are mean 6 S.E.M., #P,0.05
vs. sham group; *P,0.05 vs. vehicle+I/R group.
doi:10.1371/journal.pone.0040165.g003
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PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e40165Figure 4. Effects of TSA on expression of proinflammatory cytokines. As shown in Fig. 4A, after reperfusion, MIF content was significantly
increased at 1 hour, 3 hours, and 6 hours, reaching a maximum at 24 hours ( DP,0.05) after reperfusion in vehicle+I/R groups, showing significant
differences from sham groups (#P,0.05). TSA markedly inhibited the expression of MIF at different points in time after reperfusion (*P,0.05). No
visible difference in TNF-a expression had been induced by reperfusion at 1 hour. The elevation of TNF-a level was observed at 3 hours and 6 hours,
reaching a maximum at 24 hours (DP,0.05) after reperfusion in vehicle+I/R groups over sham groups (#P,0.05). The change of IL-6 expression was
similar to TNF-a level. The increased expression of TNF-a and IL-6 at 3 hours, 6 hours, and 24 hours after reperfusion were also down-regulated by TSA
treatment (*P,0.05).
doi:10.1371/journal.pone.0040165.g004
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Samples from all three groups (n=6 for each group) were used
for assessment. The rats were killed with chloral hydrate anesthesia
6 hours after reperfusion, and the brains were rapidly removed
and dissected. Brain samples from the ischemic hemisphere were
immediately weighed on an electronic balance and then dried in
an oven at 100uC for 24 hours to determine the dry weight. Brain
water content was calculated as follows: (wet weight 2 dry
weight)/wet weight6100%.
Measurement of Infarct Volume in the Brain
Samplesfromallthreegroups(n=6foreachgroup)wereusedfor
analysis. At 6 hours after reperfusion, rats were killed and their
brains were quickly removed and frozen at 220uC for 15 minutes.
Coronal brain sections (2 mm thick) were stained with 2% TTC at
37uC for 20 minutes followed by fixation with 4% paraformalde-
hyde. The staining images were recorded using a digital camera
(Canon Oxus 950IS) and then quantified using an Image J (ver
1.37c, NIH). To compensate for the effects of brain edema, the
corrected volume was calculated using the following equation:
Percentage hemisphere lesion volume (%HLV) = {[total infarct
volume 2 (left hemisphere volume 2 right hemisphere volume)]/
right hemisphere volume} 6100%. Infarct volume measurements
were carried out by an investigator blinded to the treatment groups.
At the 1 hour, 3 hour, 6 hour, and 24 hour marks following
sham or injury, rats were killed for sample collection (n=5–8 for
each point in time). For MPO activity assay, ELISA, Western blot,
and EMSA analyses, ischemia cortex tissue was rapidly taken from
fresh brains and immediately stored in liquid nitrogen.
MPO Assay
The accumulation of neutrophils in the ischemia cerebral cortex
was assessed by measuring MPO activity according to the
manufacturer’s instructions. Briefly, the brain tissue samples
obtained 6 hours and 24 hours after reperfusion were homoge-
nized in cool normal saline (brain tissue: normal saline=1:10).
MPO activity was measured with a spectrophotometer at 460 nm.
Cytokine ELISA
Brain tissue homogenate was prepared using samples taken at
all four points in time. Levels of MIF, TNF-a and IL-6 were
determined using commercially available ELISA kits according to
the manufacturer’s instructions.
Western Blot Analysis
The ischemic cortex was harvested for the assay of protein
expressions 24 hours after reperfusion. Western blotting was
performed as described previously [15,31]. MIF antibody (diluted
to 1:500), NF-kB p65 antibody (diluted to 1:500), and b-actin
(diluted to 1:1000) were used as primary antibodies. Blots were
subjected to gel formatter (BIO-RAD) and quantified through
Quantity One analysis. b-Actin was used as an internal loading
control.
Nuclear Protein Extraction and EMSA
Nuclear proteins from cortical tissue were extracted and
quantified as described [32,33]. In brief, frozen brain samples
were homogenized in 0.8 ml ice-cold buffer A, composed of
10 mmol/L HEPES (pH 7.9), 10 mmol/L KCl, 2 mmol/L
MgCl2, 0.1 mmol/L EDTA,1 mmol/L dithiothreitol (DTT), and
0.5 mmol/L phenylmethylsulfonyl fluoride (PMSF) (all from
Sigma Chemical Co.). The homogenates were incubated on ice
for 25 minutes and vortexed for 30 seconds after addition of 50 mL
Figure 5. Effects of TSA on expression of MIF and NF-kB p65 24
hours after I/R injury. The protein expressions of (A) MIF and (B) NF-
kB p65 in the brain tissues of the injured cerebral hemisphere were
detected by Western blot (n=6 for each group, #P,0.05 vs. sham,
*P,0.05 vs. vehicle+I/R). After TSA treatment, both the expression of
MIF and NF-kB p65 was clearly decreased relative to the vehicle+I/R
group.
doi:10.1371/journal.pone.0040165.g005
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centrifuged for 10 minutes at 5000 g at 4uC. The pellet was
suspended in 200 mL ice-cold buffer B composed of 50 mmol/L
HEPES (pH 7.9), 400 mM NaCl, 50 mmol/L KCl, 0.1 mmol/L
EDTA, 1 mmol/L DTT, and 0.5 mmol/L PMSF, and 25% (v/v)
glycerol and incubated on ice 30 minutes with frequent mixing.
After centrifugation (12,000 6g, 4uC) for 15 minutes, the
supernatants containing nuclear proteins were collected and
stored at 280uC for further analysis. Protein concentration was
determined using a bicinchoninic acid assay kit with bovine serum
albumin as the standard (Pierce Biochemicals).
EMSA was performed using a commercial kit (Gel Shift Assay
System; Promega, Madison, WI, U.S.) using methods described in
detail elsewhere [32,34]. The NF-kB consensus oligonucleotide
probe (59-AGTTGAGGGGACTTTCCCAGGC-39) was end-
labeled with [c-
32P] ATP (Free Biotech., Beijing, China) with
T4-polynucleotide kinase. Nuclear protein (15 mg) was preincu-
bated in a total volume of 9 mL in a binding buffer, consisting of
10 mmol Tris-HCl (pH 7.5), 20 mmol NaCl, 1 mmol MgCl2,
0.5 mmol DTT, 0.5 mmol EDTA, 4% glycerol, and 0.05 mg/mL
poly-(deoxyinosinicdeoxycytidylic acid) for 15 minutes at room
temperature. After addition of the 1 mL
32P-labled oligonucleotide
probe, the incubation was continued for 20 minutes at room
temperature. The reaction was stopped by adding 1 mL of gel
loading buffer. The mixture was subjected to nondenaturing 4%
polyacrylamide gel electrophoresis in a TBE buffer (Tris-borate-
EDTA). The gel was vacuum-dried and exposed to X-ray film
(Fuji Hyperfilm, Tokyo, Japan) at 280uC with an intensifying
screen. Levels of NF-kB DNA binding activity were quantified by
computer-assisted densitometric analysis.
Figure 6. NF-kB activity in the cortex of rat. (A) Nuclear proteins of brain samples of three groups were assayed for NF-kB binding activity by
EMSA 24 hours after focal cerebral I/R. Lane 1, positive control; Lane 2, sham group; Lane 3, vehicle+I/R group; Lane 4, TSA+I/R group. (B)
Quantification of NF-kB binding activity was performed by densitometric analysis. Bar graph showing the relative density of the EMSA
autoradiograph of the three groups compared to sham group. The figure indicates that cerebral NF-kB activity was significantly increased in
vehicle+I/R group (#P,0.05), which was significantly lower in the TSA treatment group than in the vehicle+I/R group (*P,0.05). Data represents
mean 6 S.E.M. (n=5 per group).
doi:10.1371/journal.pone.0040165.g006
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e40165Figure 7. Co-localization of MIF and NeuN. As shown in Fig. 7, A, B and C represent the expression of MIF in sham group, vehicle+I/R group and
TSA+I/R group respectively; D, E and F represent the expression of NeuN in sham group, vehicle+I/R group and TSA+I/R group respectively; G, H and I
represent the merger of MIF and NeuN in sham group, vehicle+I/R group and TSA+I/R group respectively. Original magnification, 6400. The
expression of MIF was increased in the vehicle+I/R group and attenuated by TSA. In the cerebral cortex, MIF was found almost all located in the
neurons in the three groups.
doi:10.1371/journal.pone.0040165.g007
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e40165Figure 8. Co-localization of MIF and GFAP. As shown in Fig. 8, A, B and C represent the expression of MIF in sham group, vehicle+I/R group and
TSA+I/R group respectively; D, E and F represent the expression of GFAP in sham group, vehicle+I/R group and TSA+I/R group respectively; G, H and I
represent the merger of MIF and GFAP in sham group, vehicle+I/R group and TSA+I/R group respectively. Original magnification,6400. The
expression of MIF was increased in vehicle+I/R group and attenuated by TSA. In the cerebral cortex, MIF was scarcely located in astrocytes in the three
groups.
doi:10.1371/journal.pone.0040165.g008
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The samples used for histological assessment in our previous
study were also used for immunofluorescence staining here.
Briefly, sections were incubated for 15 min in 1% Triton X-100 to
disrupt the cell membrane after the removal of wax and benzene.
Brain tissues were microwaved for 10 min for antigen retrieval,
and then allowed to cool down. They were then placed in PBS and
blocked with normal goat serum at 37uC for 30 min. Mouse anti-
GFAP and anti-NeuN and rabbit anti-MIF were used as primary
antibodies. Sections were incubated in primary antibody (anti-
GFAP, 1:200; anti-NeuN, 1:200; anti-MIF, 1:100) overnight at
4uC, followed by reaction for 1 h at 37uC with FITC-conjugated
goat anti-rabbit IgG antibody (1:100) and TRITC-conjugated
goat anti-mouse IgG antibody (1:200). After washing, the sections
were cover slipped with glycerin jelly. Images were captured and
digitized using a Leica laser scanning confocal microscope (Leica
TCS-SP2).
Statistical Analysis
All data are expressed as mean 6 S.E.M. The differences
between various groups were analyzed by one-way analysis of
variance (ANOVA) followed by multiple comparison tests as post
hoc comparison. The neurological deficit scores were analyzed by
Mann-Whitney U test. A level of P,0.05 was considered to be
statistically significant. Statistical software package SPSS17.0 was
used.
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